Ferritin, C-Reactive Protein, and Soluble CD25 Distinguish TAFRO From HLH
Steven Rowe1, Mariam Goubran2, Mateo Sarmiento Bustamante3
1Discipline of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
American Journal of Hematology
|September 26, 2025
Abstract:
A clinical pathway for differentiating TAFRO from HLH when a cytokine storm is identified, using ferritin, C-reactive protein, and soluble CD25.


